We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

AI-Powered Deep Learning Model Accurately Counts Cell Types in Whole Slide Images

By LabMedica International staff writers
Posted on 19 Apr 2023
Print article
Image: A deep learning framework estimating cell types in a whole slide digital pathology image (Photo courtesy of University of Eastern Finland)
Image: A deep learning framework estimating cell types in a whole slide digital pathology image (Photo courtesy of University of Eastern Finland)

Improved methods for counting cell types in pathology images using deep learning approaches are much needed. Current techniques based on segmentation and regression face challenges such as the necessity for precise pixel-level annotations, difficulties in handling overlapping nuclei or obscured regions, and insufficient information on individual cell type locations. Moreover, probabilistic models tend to yield uncertain predictions and can lead to overconfident predictions. Researchers have now developed an advanced deep learning model to predict and count various cell types in the tumor microenvironment, which is expected to enhance the accuracy and efficiency of cancer diagnostics and treatment planning.

Identifying the different cell types in the tumor microenvironment can offer valuable insights into the tumor's histology and underlying biology. Precise and reliable cell type counting is also crucial for research and clinical applications. In addition, cell counts can be used to study the distribution of different cell types in the tumor microenvironment and its correlation with patient outcomes. In clinical settings, cell counts can help monitor therapy response and track disease progression. Researchers from the University of Eastern Finland (Kuopio, Finland) have proposed a new evidential multi-task deep learning approach, called CT-EMT, to overcome the limitations of current methods for cell type counting in whole slide tumor images. This approach formulates cell type density estimation and cell type counting as regression tasks, and nuclei segmentation as a pixel-level classification task.

The proposed cell type segmentation and counting approach has outperformed state-of-the-art HoVer-Net and StarDist models, with relative improvements of 21% and 12% in terms of mean panoptic quality. The developed model can deliver persuasive interpretations of diverse cell types and can be applied to various computational pathology tasks, such as tumor grading, prognosis, and treatment planning. This work will pave the way for the creation of more accurate and robust digital pathology tools that can support pathologists and clinicians in diagnosing and treating cancer patients.

“The UEF Cancer AI research team aims to explore the potential of using deep learning technology in cancer and health data analysis,” said senior researcher Hamid Behravan of the University of Eastern Finland. “Our study will involve the development and evaluation of cutting-edge deep learning algorithms for analyzing cancer and various types of health-related data, including medical images, genomic data, and electronic health records. We believe that this approach has the potential to significantly improve the accuracy and efficiency of breast cancer diagnosis and treatment planning, as well as to facilitate the discovery of new insights and patterns in cancer data. We hope that our research will contribute to the advancement of precision medicine and the development of more effective and personalized approaches to breast cancer prevention and prognosis.”

Related Links:
University of Eastern Finland

Platinum Supplier
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
HLA-B27 Real Time PCR Test
Silver Supplier
HSV1+2 / VZV Test
Savvygen HSV1+2 / VZV

Print article


Clinical Chem.

view channel
Image: Electrochemical cells etched by laser on wooden tongue depressor measure glucose and nitrite in saliva (Photo courtesy of Analytical Chemistry)

Biosensor-Fabricated Wooden Tongue Depressor Measures Glucose and Nitrite in Saliva

Physicians often use tongue depressors to examine a patient's mouth and throat. However, it is hard to imagine that this simple wooden tool could actively assess a patient's health. This idea has led to... Read more

Molecular Diagnostics

view channel
Image: A portable smartphone-based POC device for use with EXTRA-CRISPR method for cancer diagnostics (Photo courtesy of UF Health)

CRISPR-Powered Method for Non-Invasive Blood Tests to Help Diagnose Early Stage Cancer

MicroRNAs, tiny RNA molecules that regulate gene expression, have been identified as potential cancer biomarkers in human fluids like blood. Extracellular vesicles, tiny particles actively discharged by... Read more


view channel
Image: The Atellica HEMA 570 and 580 hematology analyzers remove workflow barriers (Photo courtesy of Siemens)

Next-Gen Hematology Analyzers Eliminate Workflow Roadblocks and Achieve Fast Throughput

Hematology testing is a critical aspect of patient care, utilized to establish a patient's health baseline, track treatment progress, or guide timely modifications to care. However, increasing constraints... Read more


view channel
Image: Newly observed anti-FSP antibodies have also been found to predict immune-related adverse events (Photo courtesy of Calviri)

First Blood-Based Biomarkers Test to Predict Treatment Response in Cancer Patients

Every year worldwide, lung cancer afflicts over two million individuals and almost the same number of people succumb to the disease. This malignancy leads the charts in cancer-related mortalities, with... Read more


view channel
Image: The rapid MTB strip test for tuberculosis can identify TB patients within two hours (Photo courtesy of Chulalongkorn University)

Rapid MTB Strip Test Detects Tuberculosis in Less Than an Hour without Special Tools

Tuberculosis (TB), a highly infectious disease, continues to pose significant challenges to public health worldwide. TB is caused by a bacterium known as "Mycobacterium tuberculosis," spreading through... Read more


view channel
Electronic biosensor uses DNA aptamers for detecting biomarkers in whole blood samples (Photo courtesy of Freepik)

Electronic Biosensor Detects Biomarkers in Whole Blood Samples without Addition of Reagents

The absence of robust, reliable, and user-friendly bioanalytical tools for early and timely diagnosis of cardiovascular diseases, particularly sudden cardiac arrest, leads to preventable deaths and imposes... Read more


view channel
Image: The global hemostasis diagnostics market is expected to reach USD 3.95 billion by 2025 (Photo courtesy of Freepik)

Global Hemostasis Diagnostics Market Driven by Increase in Invasive Surgical Procedures

Injury or surgery naturally creates bleeding in living beings, which must be stopped to prevent excessive blood loss. The human body implements a protective mechanism known as hemostasis to stop excessive bleeding.... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.